State AL
Clinical Trials in Alabama
Recruiting clinical trials with at least one study location in Alabama. Data updated daily from ClinicalTrials.gov.
Top Conditions in Alabama
NCT05919511 N/A
Recruiting
Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
Condition
cGVHD
Enrollment
1,500 pts
Location
United States
Sponsor
Incyte Corporation
NCT06991114 Phase 2
Recruiting
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Ther...
Condition
Refractory Rheumatoid Arthritis (RA)
Enrollment
90 pts
Location
United States, Bulgaria, France
Sponsor
Artiva Biotherapeutics, Inc.
NCT06205121 Phase 2
Recruiting
Efficacy and Safety Study of OATD-01 in Patients With Active Pulmonary Sarcoidos...
Condition
Pulmonary Sarcoidosis
Enrollment
96 pts
Location
United States, Denmark, France
Sponsor
Molecure S.A.
NCT07025421 N/A
Recruiting
The ARISE Study - Use of Vertical Positioning
Condition
Acute Respiratory Distress Syndrome
Enrollment
40 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT05006716 Phase 1, Phase 2
Recruiting
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell M...
Condition
B-cell Malignancy
Enrollment
614 pts
Location
United States, Australia, Brazil
Sponsor
BeOne Medicines
NCT06808984 Phase 2
Recruiting
Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the ...
Condition
Agitation
Enrollment
120 pts
Location
United States
Sponsor
Celgene
NCT06079671 Phase 3
Recruiting
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (e...
Condition
Locally Advanced Cervical Cancer
Enrollment
800 pts
Location
United States, Brazil, Canada
Sponsor
AstraZeneca
NCT06806592 Phase 3
Recruiting
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to ...
Condition
Interstitial Lung Diseases
Enrollment
400 pts
Location
United States, Australia, Austria
Sponsor
Boehringer Ingelheim
NCT02402244 N/A
Recruiting
Project: Every Child for Younger Patients With Cancer
Condition
Adrenal Gland Pheochromocytoma
Enrollment
75,000 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT07400588 Phase 2
Recruiting
Aleniglipron Phase 2 in Type 2 Diabetes Mellitus
Condition
Obese
Enrollment
50 pts
Location
United States
Sponsor
Gasherbrum Bio, Inc., a wholly
NCT05096273 N/A
Recruiting
Retraining and Control Therapy (ReACT): Sense of Control and Symptom Expectation...
Condition
Convulsion, Non-Epileptic
Enrollment
68 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT07175428 Phase 2
Recruiting
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Antic...
Condition
Atrial Fibrillation (AF)
Enrollment
1,200 pts
Location
United States, Canada
Sponsor
Regeneron Pharmaceuticals
NCT04055428 Phase 2
Recruiting
NAUTICAL: Effect of Natriuretic Peptide Augmentation on Cardiometabolic Health i...
Condition
Diabetes Mellitus
Enrollment
200 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT05830201 N/A
Recruiting
The Presence of a Therapy Dog Reduces Pain and Anxiety During Pediatric Elbow Pi...
Condition
Elbow Injury
Enrollment
50 pts
Location
United States
Sponsor
University of Alabama at Birmi
NCT07431853 Phase 2
Recruiting
A Study to Learn About mRNA Vaccines Against Influenza in Adults
Condition
Healthy Adults
Enrollment
770 pts
Location
United States
Sponsor
Pfizer
NCT06728410 Phase 2
Recruiting
A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced I...
Condition
Intrahepatic Cholangiocarcinoma
Enrollment
38 pts
Location
United States
Sponsor
Mehmet Akce
NCT06513962 Phase 3
Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
60 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
NCT06307652 Phase 3
Recruiting
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Hear...
Condition
Heart Failure and Impaired Kidney Function
Enrollment
4,800 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT07276997 Phase 2
Recruiting
A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcapr...
Condition
Major Depressive Disorder
Enrollment
195 pts
Location
United States
Sponsor
AbbVie
NCT05889624 N/A
Recruiting
Responding With Evidence and Access for Childhood Headaches
Condition
Headache
Enrollment
400 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
NCT07266558 Phase 4
Recruiting
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Partic...
Condition
SARS-CoV-2
Enrollment
30,000 pts
Location
United States
Sponsor
ModernaTX, Inc.
NCT06794996 Phase 2
Recruiting
Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or...
Condition
Proteinuric Kidney Disease
Enrollment
45 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
NCT05853783 N/A
Recruiting
Evaluation of Oral Potentially Malignant Disorders (OPMDs) with STRATICYTE™
Condition
Mouth Diseases
Enrollment
180 pts
Location
United States
Sponsor
Proteocyte Diagnostics Inc.
NCT06177717 N/A
Recruiting
Deep Functional Phenotyping of the ALA Lung Health Cohort
Condition
Lung Diseases
Enrollment
1,000 pts
Location
United States
Sponsor
Johns Hopkins University
NCT05006482 Phase 3
Recruiting
Geriatric Evaluation and Management With Survivorship Health Education for Older...
Condition
Lymphoma
Enrollment
668 pts
Location
United States
Sponsor
University of Rochester
Page 1 of 8 — 178 trials total